OC
CCRN icon

Oppenheimer & Co’s Cross Country Healthcare CCRN Stock Holding History

Oppenheimer & Co’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,827
Closed -$447K – 1390
2022
Q4 		$447K Buy
+16,827
New +$549K 0.01% 947

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Oppenheimer & Co's CCRN Position: Q1 2023 in Review

Oppenheimer & Co sold out of Cross Country Healthcare (CCRN) in Q1 2023, closing a stake of 16,827 shares — an estimated $447K sold.

Oppenheimer & Co first reported a position in CCRN in Q4 2022 and held it in 1 quarter. The position peaked at $447K in Q4 2022. 201 funds tracked by Wall St. Rank hold CCRN as of Q1 2023.

  • Oppenheimer & Co reported no remaining Cross Country Healthcare position as of Q1 2023 after selling out during the quarter.
  • Oppenheimer & Co sold 16,827 Cross Country Healthcare shares in Q1 2023, an estimated $447K.
  • Oppenheimer & Co first reported a position in Cross Country Healthcare in Q4 2022 and held it in 1 quarter.
  • Oppenheimer & Co's Cross Country Healthcare position peaked at $447K in Q4 2022.
  • 201 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2023.

Based on Oppenheimer & Co's 13F filing for Q1 2023, filed 10 May 2023.